2 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow AGS-16C3F: new trials by email Literature Review of AGS-16C3F trials Research Report on AGS-16C3F
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of AGS-16C3F vs. Axitinib in Metastatic Renal Cell Carcinoma AGS-16C3F, Axitinib - Metastatic Renal Cell Carcinoma | Phase 2 | Completed | Astellas Pharma Global Development, Inc. | 133 | 2016-05-03 | 2024-11-18 |
| A Study to Assess the Safety, Pharmacokinetics and Effectiveness of AGS-16C3F Monotherapy in Subjects With Renal Cell Carcinoma (RCC) of Clear Cell or Papillary Histology AGS-16C3F - Carcinoma, Renal Cell, Renal Cell Carcinoma of Papillary Histology | Phase 1 | Completed | Agensys, Inc. | 34 | 2012-07-18 | 2024-11-01 |
Agensys, Inc. (1) · Astellas Pharma Global Development, Inc. (1)
Canada (2) · United States (2)